Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Characterizing Transcranial Focused Ultrasound Neuromodulation During Sedation
NCT07161518Phase 4Enrolling by invitation
- Sponsor
- Stanford University
- Start
- Sep 2025
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
Phase 4, randomised trial (2 arms), sponsored by Stanford University. Primary endpoint: Electroencephalographic power spectral density at 3 hours. Started Sep 2025; status: enrolling by invitation.
Beyond the preview
Go deeper on NCT07161518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07161518.